Vaccitech (VACC) News Today $1.37 -0.09 (-6.16%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 22, 2024 | americanbankingnews.comComparing CytoDyn (OTCMKTS:CYDY) & Vaccitech (NASDAQ:VACC)July 20, 2024 | marketbeat.comM&G Plc Makes New $25.99 Million Investment in Vaccitech plc (NASDAQ:VACC)M&G Plc purchased a new stake in Vaccitech plc (NASDAQ:VACC - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 5,197,349 shares of the company's stock, valued at approximately $25,987,000June 27, 2024 | marketbeat.comVaccitech (NASDAQ:VACC) Shares Down 0.4% Vaccitech (NASDAQ:VACC) Trading Down 0.4%June 5, 2024 | marketbeat.comVaccitech (NASDAQ:VACC) Trading Down 5.5%Vaccitech (NASDAQ:VACC) Stock Price Down 5.5%May 22, 2024 | markets.businessinsider.comBarinthus Bio to Present VTP-300 Clinical Data Updates at EASL Congress 2024May 17, 2024 | markets.businessinsider.comBuy Rating for Barinthus Biotherapeutics Backed by Strong Financials and Promising Clinical TrialsApril 30, 2024 | msn.comWhat is AstraZeneca Vaccine? Know the Recently Discovered Side Effects of the COVID-19 AntibodyApril 19, 2024 | markets.businessinsider.comBuy Rating on Barinthus Biotherapeutics Backed by Promising Clinical Trials and Strong Valuation ProspectsApril 6, 2024 | msn.comLondon is a bad place to raise money, says life sciences tsar Sir John BellMarch 2, 2024 | seekingalpha.comArbutus Biopharma Corporation (ABUS) Q4 2023 Earnings Call TranscriptJanuary 8, 2024 | markets.businessinsider.comPositive Clinical Outlook and Strong Capital Position Justify Buy Rating for Barinthus BiotherapeuticsJanuary 8, 2024 | finanznachrichten.deBarinthus Biotherapeutics: Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate MilestonesJanuary 5, 2024 | finance.yahoo.comBarinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate MilestonesDecember 22, 2023 | markets.businessinsider.comBuy Rating for Barinthus Biotherapeutics: Promising Pipeline and Strategic Partnerships Signal Investment OpportunityDecember 21, 2023 | markets.businessinsider.comBarinthus Biotherapeutics Collaborates With CEPI And University Of Oxford For New MERS VaccineDecember 21, 2023 | finance.yahoo.comNew partnership aims to advance vaccine against MERS coronavirusDecember 13, 2023 | finance.yahoo.comInfluenza Vaccine Market to grow by USD 2.93 billion from 2022 to 2027; North America to account for 54% of market growth - TechnavioNovember 28, 2023 | markets.businessinsider.comAnalysts’ Top Healthcare Picks: Barinthus Biotherapeutics (BRNS), Anavex Life Sciences (AVXL)November 15, 2023 | finance.yahoo.comBarinthus Biotherapeutics plc (BRNS)November 9, 2023 | finance.yahoo.comBarinthus Bio Reports Third Quarter 2023 Financial Results and Recent Corporate DevelopmentsNovember 8, 2023 | money.usnews.comBarinthus Biotherapeutics Plc. - ADRNovember 7, 2023 | msn.comBarinthus stock falls 18%, day after changing name from VaccitechNovember 6, 2023 | msn.comVaccitech rebrands as Barinthus, plans to present data at AASLD meetingNovember 6, 2023 | finance.yahoo.comVaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution into a T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, and CancerSeptember 28, 2023 | seekingalpha.comSIRI, EC and PBTS among pre-market losersSeptember 26, 2023 | 247wallst.comMorgan Stanley Downgrades VaccitechSeptember 26, 2023 | uk.finance.yahoo.comInnovative Therapeutic Cancer Vaccines Drive Unprecedented Growth in Global Cancer Vaccines Market to 2028September 26, 2023 | seekingalpha.comVaccitech surges despite Morgan Stanley downgradeSeptember 26, 2023 | finance.yahoo.comVaccitech plc (NASDAQ:VACC) surges 85%; individual investors who own 44% shares profited along with institutionsSeptember 25, 2023 | benzinga.comGlobal Cancer Vaccines Market to Skyrocket, Projected to Reach $12.1 Billion by 2028September 25, 2023 | marketwatch.comHealth Care Up on Defensive Bets -- Health Care RoundupSeptember 25, 2023 | msn.comMorgan Stanley Downgrades Vaccitech plc - ADR (VACC)September 25, 2023 | marketwatch.comVaccitech Shares Surge as Alliance Global Initiates CoverageSeptember 25, 2023 | marketbeat.comTrading was temporarily halted for "VACC" at 12:09 PM with a stated reason of "LULD pause."September 13, 2023 | finance.yahoo.comVaccitech to Host KOL Webinar on Seeking a Functional Cure for Chronic Hepatitis B on September 20, 2023September 12, 2023 | bizjournals.comArbutus BioPharma narrows research focus to extend cash runwayAugust 10, 2023 | finanznachrichten.deVaccitech plc: Vaccitech Reports Second Quarter 2023 Financial Results and Recent Corporate DevelopmentsAugust 10, 2023 | finance.yahoo.comVaccitech Reports Second Quarter 2023 Financial Results and Recent Corporate DevelopmentsAugust 9, 2023 | finance.yahoo.comVaccitech (NASDAQ:VACC) shareholders have endured a 50% loss from investing in the stock a year agoJune 22, 2023 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Vaccitech Plc (VACC) and Aeglea Biotherapeutics (AGLE)June 13, 2023 | markets.businessinsider.comAnalyst Expectations for Vaccitech's FutureJune 12, 2023 | finance.yahoo.comVaccitech Doses First Patient in PCA001, a Prostate Cancer Phase 1/2 Clinical Trial of VTP-850 Immunotherapeutic Candidate in Men with Rising PSA after Definitive Local TherapyMay 19, 2023 | finance.yahoo.comNewsflash: Vaccitech plc (NASDAQ:VACC) Analysts Have Been Trimming Their Revenue ForecastsMay 17, 2023 | markets.businessinsider.comAnalysts’ Top Healthcare Picks: Arcus Biosciences (RCUS), Vaccitech Plc (VACC)May 16, 2023 | msn.comMorgan Stanley Maintains Vaccitech plc - ADR (VACC) Overweight RecommendationMay 12, 2023 | msn.comVaccitech: Q1 Earnings InsightsMay 12, 2023 | finance.yahoo.comVaccitech Reports First Quarter 2023 Financial Results and Recent Corporate DevelopmentsMay 5, 2023 | finance.yahoo.comRevenues Working Against Vaccitech plc's (NASDAQ:VACC) Share PriceApril 17, 2023 | finance.yahoo.comVaccitech Presents Interim Data from Phase 1b/2 Study of VTP-200 at 35th Annual International Papillomavirus Conference (IPVC) Highlighting Favorable Tolerability and Immunogenicity ProfileMarch 30, 2023 | marketwatch.comGlobal Influenza Vaccines Market Size 2023 to 2026 Size and Share Survey Report Get Vaccitech News Delivered to You Automatically Sign up to receive the latest news and ratings for VACC and its competitors with MarketBeat's FREE daily newsletter. Email Address We just added a $300 account credit to your MarketBeat subscription (Ad)MarketBeat All Access is our complete suite of portfolio monitoring software, research tools, stock screeners, proprietary reports, and more. Upgrade today and get $300 off your 2024-2025 subscription. Free for 30 days. Start Your Risk-Free Trial Here VACC Media Mentions By Week VACC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VACC News Sentiment▼0.580.62▲Average Medical News Sentiment VACC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VACC Articles This Week▼20▲VACC Articles Average Week Get Vaccitech News Delivered to You Automatically Sign up to receive the latest news and ratings for VACC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Shattuck Labs News Today Ventyx Biosciences News Today Abeona Therapeutics News Today Generation Bio News Today Eliem Therapeutics News Today Pyxis Oncology News Today Renovaro News Today Trevi Therapeutics News Today Greenwich LifeSciences News Today Biomea Fusion News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VACC) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccitech plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccitech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.